Target intelligence / Profile preview

Cell cycle regulatory proteins and Caspase-3

Molecular classification
Enzyme, Transcription factor, Other
01

Overview

Cell cycle regulatory proteins and Caspase-3 represent a collective group of proteins that orchestrate the balance between cell division and programmed cell death. Cell cycle regulatory proteins, such as Cyclin-Dependent Kinases (CDKs) and their associated cyclins, control the orderly progression of cells through the division phases (G1, S, G2, and M) [PubMed 28273103]. Caspase-3 is a cysteine-aspartic acid protease that serves as the primary executioner of apoptosis, responsible for the proteolytic cleavage of numerous key proteins leading to cell disassembly [UniProt P42574]. In many disease states, particularly cancer, the cell cycle is dysregulated, leading to uncontrolled proliferation, while apoptotic pathways are often suppressed to avoid cell death [PubMed 11060336]. Therapeutic strategies frequently involve inhibiting cell cycle regulators to induce arrest, which often acts as a precursor to the activation of Caspase-3 and subsequent apoptosis [PubMed 30633411]. Consequently, these proteins are central to the mechanism of action for a wide range of oncology treatments, from targeted kinase inhibitors like Palbociclib to broad-spectrum cytotoxic agents [StatPearls NBK537027].

Other names
Cell cycle and apoptotic machineryCDK-Caspase axisCell cycle regulators and executioner caspases
02

Mechanism of action

Inhibition of cyclin-dependent kinases (CDKs) to induce cell cycle arrest at specific checkpoints (e.g., G1/S); Activation of the apoptotic cascade leading to the proteolytic activation of Caspase-3 and subsequent cell disassembly.

03

Biological functions

Cell cycleApoptosisCell proliferationCell death
04

Disease associations

CancerNeurodegenerative diseaseInflammation
05

Safety considerations

Hematologic toxicities (e.g., neutropenia, anemia, leukopenia)Gastrointestinal distressFatiguePotential for systemic toxicity due to inhibition of normal cell turnover in healthy tissues
06

Interacting drugs

Palbociclib

6 more in the full profile.

07

Biomarkers

Ki-67 expressionCleaved Caspase-3 levelsCyclin D1 amplificationp16INK4a expressionPARP cleavage

Beyond the preview

Go deeper on Cell cycle regulatory proteins and Caspase-3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell cycle regulatory proteins and Caspase-3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call